Physician profile
Ankush Goel
NPI 1821315961
$6,851.78
in general payments reported to CMS, 2019-2025
31 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $413 · 2021: $763 · 2022: $557 · 2023: $907 · 2024: $2,074 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,286.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $926.00 | 2021-2025 | Hawkone, Corevalve Evolut R, Abre |
| Abiomed | $835.25 | 2020-2025 | Impella |
| Angiodynamics, INC. | $739.57 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $626.87 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Tactile Systems Technology INC | $414.75 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $398.93 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $345.60 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $252.30 | 2022 | |
| Abbott Laboratories | $247.27 | 2019-2025 | Cardiomems |
| Cardiac Dimensions, INC. | $241.65 | 2023 | |
| Imperative Care, INC | $231.57 | 2025 | Prodigy Catheter, Symphony Catheter |
| Inari Medical, INC. | $193.21 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $161.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $154.64 | 2019-2022 | |
| Boston Scientific Corporation | $139.98 | 2019-2024 | Watchman Access System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $123.81 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $116.78 | 2025 | Uptravi, Opsumit |
| Veryan Medical Incorporated | $101.19 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $84.86 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $79.60 | 2024 | Assure Wcd |
| Stryker Corporation | $73.81 | 2024 | Vsp System, Vsp Cranial |
| Pfizer INC. | $66.24 | 2019-2021 | |
| Teleflex LLC | $54.60 | 2025 | Turnpike |
| Cardiva Medical, INC. | $53.28 | 2022 | |
| W. L. Gore & Associates, INC. | $44.02 | 2022 | |
| Becton, Dickinson and Company | $41.85 | 2025 | Rotarexs 6 F X 135 Cm, Lifestream |
| Cook Medical LLC | $38.13 | 2024-2025 | Rosen |
| Cordis US Corp. | $28.59 | 2024-2025 | Mynxgrip |
| Amgen INC. | $17.75 | 2019 | |
| Philips North America LLC | $15.28 | 2019 | |
| Surmodics, INC. | $2.49 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Pounce Thrombectomy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankush Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.